At the moment, there is a lack of clinically relevant preclinical models for fatty liver disease. This problem has led to most drug candidates that were successful in preclinical development ...

Their research has led to the development of a promising new drug that could change the treatment landscape for this ...

The research team led by Dr. Hyunwoo Kim and Dr. Myungae Bae at the Korea Research Institute of Chemical Technology (KRICT) ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD) ...

Nat Clin Pract Gastroenterol Hepatol. 2009;6(1):18-19. Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases in the Western world. NAFLD is associated with chronic ...

Based on the association of CVD, diabetes and metabolic syndrome with the development and progression of NAFLD, the management of NAFLD should include aggressive management of cardiovascular risk ...

Further worrisome are recent data showing a high prevalence of NAFLD in obese Indian children.” Today, an increasing number of children are affected by Non-Alcoholic Fatty Liver Disease.

Recent figures show that around 63% of UK adults are either overweight or obese, and it's estimated that one in three have early-stage non-alcoholic fatty liver disease (NAFLD). NAFLD is a term ...